Rogaine Women's Disease Interactions
There is 1 disease interaction with Rogaine Women's (minoxidil topical).
Minoxidil topical (applies to Rogaine Women's) systemic effects
Moderate Potential Hazard, Low plausibility. Applicable conditions: Congestive Heart Failure, Fluid Retention, Sunburn, Arrhythmias, Ischemic Heart Disease
In general, topically applied minoxidil is poorly absorbed from the normal, intact scalp. However, alteration in scalp epidermal integrity (e.g., abrasion, sunburn, psoriasis) can increase percutaneous absorption with resultant systemic effects, including sodium and water retention, local or generalized edema, pericardial effusion, pericarditis, tamponade, tachycardia, and worsening or development of angina. Therapy with minoxidil should be avoided in patients with diminished or altered scalp integrity that may lead to enhanced systemic absorption, particularly in the presence of underlying cardiovascular dysfunction or fluid retention.
References (4)
- Leenen FH, Smith DL, Unger WP (1988) "Topical minoxidil: cardiac effects in bald men." Br J Clin Pharmacol, 26, p. 481-5
- Woodside J Jr, Garner L, Beford RF, et al. (1984) "Captopril reduces the dose requirement for sodium nitroprusside induced hypotension." Anesthesiology, 60, p. 413-7
- Whitmore SE, Wigley FM, Wise RA (1995) "Acute effect of topical minoxidil on digital blood flow in patients with raynaud's phenomenon." J Rheumatol, 22, p. 50-4
- (1995) "PDR Generics." Montvale, NJ: Medical Economics
Switch to consumer interaction data
Rogaine Women's drug interactions
There are 39 drug interactions with Rogaine Women's (minoxidil topical).
More about Rogaine Women's (minoxidil topical)
- Rogaine Women's consumer information
- Check interactions
- Compare alternatives
- Reviews (6)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous topical agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Kenalog-40
Kenalog-40 is a long-acting corticosteroid injection for intramuscular (into the muscle) or ...
Olumiant
Olumiant is used to treat rheumatoid arthritis, alopecia areata (hair loss), and COVID-19. Includes ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zilretta
Zilretta (triamcinolone injection) is used for the management of osteoarthritis pain of the knee ...
Rogaine
Rogaine (minoxidil) is used to help regrow new, thicker hair and prevent future hair loss in men ...
Litfulo
Litfulo is used to treat severe alopecia areata in adults and adolescents 12 years and older to ...
Ritlecitinib
Ritlecitinib is used to improve hair loss in adults and adolescents aged 12 and older with severe ...
Baricitinib
Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, alopecia areata (hair ...
Triamcinolone
Triamcinolone is used to treat allergies, skin conditions, ulcerative colitis, and arthritis. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.